These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3572978)

  • 1. Antisecretory activity of human, dog, and rat metabolites of fenoctimine.
    Scott MK; Jacoby HI; Bonfilio AC; Corcoran TW; Lopez IS
    J Med Chem; 1987 May; 30(5):894-9. PubMed ID: 3572978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisecretory activity of fenoctimine in rat and dog.
    Jacoby HI; Bonfilio AC; Corcoran T; Lopez I; Scott M
    Dig Dis Sci; 1984 Dec; 29(12):1131-6. PubMed ID: 6499632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-(Diphenylmethyl)-1-[(imino)methyl]piperidines as gastric antisecretory agents.
    Scott MK; Jacoby HI; Mills JE; Bonfilio AC; Rasmussen CR
    J Med Chem; 1983 Apr; 26(4):535-8. PubMed ID: 6834385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
    Reenstra WW; Shortridge B; Forte JG
    Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated gastric mucosa: an early approach to the study of the mechanism of action of gastric antisecretory agents.
    Colombo M; Fort M; Farré AJ
    Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):621-34. PubMed ID: 2573753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and gastric acid antisecretory properties of the H2-receptor antagonist. N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]thieno[3,4-d]isot hiazol-3-amine 1,1-dioxide and related derivatives.
    Santilli AA; Scotese AC; Morris RL; Schiehser GA; Teller DM; Nielsen ST; Strike DP
    J Med Chem; 1988 Jul; 31(7):1480-6. PubMed ID: 2898534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of food stimulated acid secretion by fenoctimine, a new anti-secretory agent.
    Williams JG; Robertson RJ; Milton-Thompson GJ
    Br J Clin Pharmacol; 1983 Jun; 15(6):673-6. PubMed ID: 6871066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric antisecretory agents. 2. Antisecretory activity of 9-[(aminoalkyl)thio]-9H-xanthenes and 5-[(aminoalkyl)thio]-5H-[1]benzopyrano[2,3-b]pyridines.
    Bristol JA; Gold EH; Gross I; Lovey RG; Long JF
    J Med Chem; 1981 Aug; 24(8):1010-3. PubMed ID: 7328593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The state of the art of gastric antisecretory drugs].
    Okabe S; Miyake H
    Nihon Yakurigaku Zasshi; 1993 Sep; 102(3):235-44. PubMed ID: 8406234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
    Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon WA
    Eur J Pharmacol; 1985 Jun; 112(2):211-24. PubMed ID: 4029260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanisms of the antisecretory and cytoprotective actions of SCH 28080.
    Chiu PJ; Casciano C; Tetzloff G; Long JF; Barnett A
    J Pharmacol Exp Ther; 1983 Jul; 226(1):121-5. PubMed ID: 6306218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory cholinergic effects of esaprazole on gastric secretion and plasma gastrin levels in the dog.
    Blandizzi C; Mengozzi G; Intorre L; Natale G; Soldani G; Del Tacca M
    Pharmacology; 1993 Apr; 46(4):231-40. PubMed ID: 8483969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and identification of the metabolites of fenoctimine using in vitro drug metabolizing systems.
    McKown LA; Wu WN; O'Neill PJ
    J Pharm Biomed Anal; 1994 Jun; 12(6):771-5. PubMed ID: 7918779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.
    Sanfilippo PJ; Urbanski M; Press JB; Hajos ZG; Shriver DA; Scott CK
    J Med Chem; 1988 Sep; 31(9):1778-85. PubMed ID: 2842503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the long acting gastric antisecretory activity of LM 24056 a non H2 antagonist.
    Mizoule J; Rataud J; Le Fur G; Jozefczak C; Quarteronet D; Uzan A
    Life Sci; 1982 Oct; 31(14):1473-85. PubMed ID: 7144436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ulcer and antisecretory activity of selected imidazopiperidines.
    Arcari G; Bernardi L; Cimaschi R; Falconi G; Luini F; Scarponi U
    Arzneimittelforschung; 1984; 34(11):1467-71. PubMed ID: 6543121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermine as a gastric antisecretory agent.
    Hada R; Martin JS; Tansy MF
    Dig Dis Sci; 1985 Aug; 30(8):808-10. PubMed ID: 4017838
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo biotransformation of fenoctimine in rat, dog and man.
    Wu WN; Hills JF; Chang SY
    Xenobiotica; 1994 Nov; 24(11):1133-48. PubMed ID: 7701854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.